Xhale, Inc. Press releases
Oct 05, 2015
Xhale Assurance, developer of the Nasal Alar SpO2 ™ Sensor, to be exhibiting at Air Medical Transport Conference & ANESTHESIOLOGY™ 2015 Annual Meeting in October.
Sep 22, 2015
Xhale submits Biomarker Qualification package to FDA for Medication Adherence Monitoring Tool. Xhale, Inc.
Mar 19, 2015
Xhale Assurance Announces FDA Approval of its Second Generation Nasal AlarSpO2TM Sensor
Jul 31, 2014
The Board of Directors of Xhale, Inc. today announced the appointment of Nauman (Nick) Toor as a board member of Xhale, Inc. Mr.
Jun 10, 2014
SMART® solution which enables the management of medication adherence and clinical trial outcomes highlighted at ASCP Annual Meeting, International HIV Adherence Conference, and the Catalent Institute Innovation Symposium
Apr 16, 2014
Xhale Awarded NIH/NIMH SBIR Grant for Monitoring Microbicide Gel Use
Jan 17, 2014
Assurance® Alar One-Sense™ Pulse Oximetry Sensor to be Presented in Two Clinical Abstracts and an Educational Session at Society for Technology in Anesthesiology Meeting
Oct 10, 2013
Assurance® Alar One-Sense™ Pulse Oximetry Sensor Highlighted in Three Clinical Presentations at American Society of Anesthesiologists Annual Meeting A New Technology “Right Under Our Nose” – Highlights Benefits of Pulse Oximetry Monitoring at...
May 03, 2013
New Device Surmounts Shortcomings of Existing Fingertip Sensors
Apr 16, 2013
- Unique Nasal Ala Pulse Oximetry Sensor - - Alar Sensing Promises High-Levels of Accuracy, Stability and Monitoring Reliability – - Sensor Compatible with Large, Existing Installed Base of Pulse Oximeters –